// company-profile

Dyne Therapeutics, Inc.

DYN
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings215Insiders27
// api This Dyne Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 10 insiders purchased shares (net $114K). Buying was led by Posner Brian S.

// 90-day insight

Over the last 90 days, Dyne Therapeutics, Inc. insiders bought $157K across 11 transactions with no open-market sales.

  • Most active insider: Rhodes Jason P with 30 transactions totaling $12.1M.
  • Largest single sale: $2.2M by Rhodes Jason P on Apr 28, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Dyne Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$2.64B
QoQ change
-7.7%
Reporting period
2026-03-31
#1
JANUS HENDERSON GROUP PLC
CIK 1274173
$245.6M
13.5M shares
#2
Atlas Venture Life Science Advisors, LLC
CIK 1917529
$165.5M
9.1M shares
#3
Orbis Allan Gray Ltd
CIK 1663865
$122.2M
6.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026Kersten DirkDYN
Sale10b5
46,901$20.07$941K
Jun 17, 2026Kersten DirkDYN
Sale10b5
37,454$20.14$754K
Jun 16, 2026Kerr DouglasDYN
Sale10b5
887$18.33$16K
Jun 16, 2026Friedl-Naderer JohannaDYN
Sale10b5
145$18.33$3K
Jun 16, 2026Cox JohnDYN
Sale10b5
2,683$18.33$49K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.